Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer-Reference-Cited by-同舟云学术

Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer

Published:2023-06-19 Issue:1 Volume:14 Page:622-636
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Mahalingam Devalingam¹²,Hanni Salih¹,Serritella Anthony V.²,Fountzilas Christos¹³,Michalek Joel¹,Hernandez Brian¹,Sarantopoulos John⁴,Datta Paromitta⁵,Romero Ofelia¹,Pillai Sureshkumar Mulampurath Achutan¹,Kuhn John¹,Pollak Michael⁶,Thompson Ian M.¹⁷

Affiliation:

1. Division of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA

2. Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA

3. Roswell Park Cancer Institute, Buffalo, NY 14263, USA

4. Institute for Drug Development, Mays Cancer Center at University of Texas Health, San Antonio, TX 78229, USA

5. Audie Murphy VA Hospital, San Antonio, TX 78229, USA

6. Division of Experimental Medicine, Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montreal, Canada

7. Christus Health, San Antonio, TX 78229, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Reference61 articles.

1. Cancer statistics, 2022;Jemal;CA Cancer J Clin,2022

2. Androgen deprivation therapy in the treatment of locally advanced, nonmetastatic prostate cancer: practical experience and a review of the clinical trial evidence;Peltier;Ther Adv Urol,2017

3. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer;Trump;N Engl J Med,1999

4. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline;Wade;J Clin Oncol,2007

5. Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer;Suissa;Eur Urol,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Will AMPK be a potential therapeutic target for hepatocellular carcinoma?;American Journal of Cancer Research;2024